Mitchell Capital Management CO Corcept Therapeutics Inc Transaction History
Mitchell Capital Management CO
- $499 Million
- Q2 2025
A detailed history of Mitchell Capital Management CO transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Mitchell Capital Management CO holds 55,583 shares of CORT stock, worth $3.84 Million. This represents 0.82% of its overall portfolio holdings.
Number of Shares
55,583
Previous 63,747
12.81%
Holding current value
$3.84 Million
Previous $7.28 Million
43.98%
% of portfolio
0.82%
Previous 1.44%
Shares
2 transactions
Others Institutions Holding CORT
# of Institutions
474Shares Held
84.4MCall Options Held
1.43MPut Options Held
2.75M-
Black Rock Inc. New York, NY16.5MShares$1.14 Billion0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.98MShares$690 Million0.02% of portfolio
-
Ingalls & Snyder LLC New York, NY7.74MShares$535 Million29.09% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.14MShares$425 Million1.13% of portfolio
-
Parallel Advisors, LLC3.87MShares$268 Million5.83% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $7.41B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...